NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hummingbird Diagnostics GmbH

Hummingbird Diagnostics GmbH

Private
HeidelbergHealthcare & Life Scienceshttps://www.hummingbird-diagnostics.com/

Last Round

Grant

Apr 29, 2020

Total Funding Raised

$708,382

Company Overview

Hummingbird Diagnostics GmbH is a biotechnology company that develops small RNA-based blood tests for the early detection and characterization of diseases, with an initial focus on lung cancer and Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical AI, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

molecular diagnosticsliquid biopsysmall RNA biomarkersearly disease detectionprecision medicineAI-powered diagnosticsbiomarker discoverylung cancer diagnosticsRNA diagnosticsmolecular contract research organizationCROclinical trial serviceslaboratory-developed testsLDTsAlzheimer's diagnosticsimmunotherapy response

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hummingbird Diagnostics GmbH Comparables

Compare Hummingbird Diagnostics GmbH with similar companies based on industry and business-model similarity.

Hummingbird Diagnostics GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exai Bio
80%
Flomics Biotech
79%
Aptorum Group Limited
78%

Hummingbird Diagnostics GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 29, 2020
SeedJan 1, 2016

Key People

Founding team and executive leadership

Rastislav Horos

Chief Technology Officer

Executive Team

Hummingbird Diagnostics GmbH Investors

Notable investors and investment history

Hummingbird Diagnostics GmbH investors
InvestorRounds
GreyBird VenturesVC Round, Seed
Alzheimer's Drug Discovery FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 4, 2026

    Monthly visitors increased 347% MoM.

Hummingbird Diagnostics GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hummingbird Diagnostics GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hummingbird Diagnostics GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersHeidelberg
Employee Range29
Year Founded2015
Last FundingApr 29, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.